GAPVD1 and ANKFY1 Mutations Implicate RAB5 Regulation in Nephrotic Syndrome
Tobias Hermle(University Medical Center Freiburg), Friedhelm Hildebrandt(Boston Children's Hospital), Tilman Jobst‐Schwan(Harvard University), Laura S. Finn(Seattle Children's Hospital), Jameela A. Kari(King Abdulaziz University), Heidi L. Rehm(Unknown), Amar J. Majmundar(Boston Children's Hospital), Monkol Lek(Massachusetts General Hospital), Joel D. Hernandez(Providence Sacred Heart Medical Center), Jillian K. Warejko(United Nations), Daniela A. Braun(University Hospital Münster), Eugen Widmeier, Shazia Ashraf(Riphah International University), Richard P. Lifton(Rockefeller University), Sherif El Desoky(King Abdulaziz University), Ronen Schneider(MACOM (United States)), Shrikant Mane(Yale Cancer Center), Jia Rao(Shanghai Jiao Tong University), Ankana Daga, Shirlee Shril(MACOM (United States)), Arvind Bagga(All India Institute of Medical Sciences), Velibor Tasić(University Clinic of Traumatology), Amelie T. van der Ven, Makiko Nakayama, David Schapiro, Daniel G. MacArthur(Garvan Institute of Medical Research), Sawsan M. Jalalah(King Abdulaziz University), Kristen M. Laricchia(Broad Institute)
Cited by 67
Related Papers
The mutational constraint spectrum quantified from variation in 141,456 humans
|bioRxiv (Cold Spring Harbor Laboratory)|2019|1.8k